GLG News by Physicians who Treat Diabetic Foot Ulcers

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

A Low Cost EMR System From Wal-Mart?

March 16, 2009

Analysis of:Wal-Mart Plans to Market Digital Health Records System | www.nytimes.com

Wal-Mart is one of the top consumer retailers in the country.  They have already entered the world of competitive, low cost health care delivery with their $4.00 generic prescriptions and their Nurse Practitioner run clinics--so becoming a warehouse for state-of-the-art electronic medical records (EMR's) is a natural progression.  I see this as a great business move for Wal-Mart as they will combine their buying power with Dell's technology expertise, creating an affordable EMR system to revolutionize American medicine.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

Health Care in America--An Ailing Commodity That Doctors Can't Cure

January 30, 2009

Analysis of:Perspectives on Health Reform, 17th January 2009 | healthaffairs.org

Fixing the health care system in America is like trying to fix the economy.  We keep dumping more and more money into it, only to find ourselves going nowhere.  There seems to be a renewed sense of hope with the emergence of a new administration in Washington, but there are no easy solutions.  We are a country endeared to our ever increasingly expensive technology, which everyone wants, but only few can afford.  We treat everyone who needs medical care, whether or not they can afford it, taking the position that hospitals and doctors will absorb the cost.  Well, hospitals and yes doctors, are going out of business.  Until the actual issues are looked at and tough decisions are made, we will find ourselves in a situation of a government run, nationalized health care system (ala Canada) which will set medicine in America back to the stone ages.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

High End Medical Devices and Implants Are Not Immune to This Recession

January 22, 2009

Analysis of:Medical devices not immune to recession worries | www.boston.com

As America faces one of the worst recessions in history, all businesses suffer, including the health care industry.  With the steady rise of unemployment, more and more people are losing their jobs, and with it their health insurance.  This has a direct impact on medical device companies, as non-emergent surgical procedures and services are put off as long as possible, thus limiting the usage of their products.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

And yet, another filler? Is this the Holy Grail?

July 8, 2008

Analysis of:FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com

Over the past few years, noninvasive cosmetic procedures have skyrocketed.  Soft tissue injectable fillers are among those procedures that are rapidly growing.  Up until now, hyaluronic acid (HA) fillers have been the mainstay.  With the emergence of Envolence, we have a new twist on an old product--collagen.  Since this does not involve skin testing and can be used at the same time as the patient's initial visit, this may prove to be an exciting new product, and may capture a fair share of the injectable filler market place.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

Stay Away From Liquid Silicone Injections.

May 27, 2008

Analysis of:Renal Failure Linked to Cosmetic Soft-Tissue Filler Injections | www.medscape.com

Only FDA approved fillers administered by experienced, licensed physicians should be injected into patients.  Also, the small volumes that are used today should not pose systemic problems that were seen in this article.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

Topical "Botox"--Sounds Like a Winner

December 14, 2007

Analysis of:Medicis and Revance Announce Strategic Collaboration | www.pipelinereview.com

It is not unexpected that Medicis is expanding into the "Botox" business since its rival company, Allergan, has a monopoly on the market.  Allergan also has Juviderm, which competes directly with Restylane, the hit product by Medicis.  This will place Medicis back into the competitive market place.

Alan ZaccariaPlastic SurgeonMD ALAN FACS ZACCARIA

Save your money SNN

May 17, 2007

Analysis of:Smith & Nephew (SNN) to Acquire BlueSky Medical Group | www.streetinsider.com

Blue Sky has not been able to capture significant market share. VAC, by KCI has cornered the market of negative pressure wound therapy.

Page : 11 to 7 of 7